CRISPR Therapeutics AG
CRSP | NASDAQ
$50.45
-$0.97 (-1.89%)
Nov 2, 2026, 11:02 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -214.09M | -122.93M | -130.61M | -106.44M | -208.55M | -136M | -37.31M | -85.94M | -126.41M | -116.59M | 89.35M | -112.15M | -77.74M | -53.07M | -110.58M | -174.55M | -185.83M | -179.22M | -141.25M | -127.15M | 759.23M | -113.16M |
Depreciation & Amortization | 8.6M | 4.32M | 5.66M | 4.43M | 4.65M | 4.74M | 4.84M | 4.74M | 4.85M | 4.83M | 4.9M | 4.93M | 4.96M | 5.05M | 5.85M | 5.02M | 7.27M | 6.04M | 6.26M | 5.32M | 3.65M | 2.72M |
Stock-Based Compensation | 33.64M | n/a | 18.08M | 16.6M | 17.61M | 20.21M | 21.95M | 21.54M | 23.67M | 19.41M | 18.42M | 19.97M | 21.77M | 20.88M | 22.81M | 24.55M | 24.85M | 25.75M | 25.77M | 26.2M | 28.33M | 22.09M |
Other Working Capital | -19.11M | -2.39M | 22.64M | -1.27M | -1.81M | 29.85M | 646K | -40.36M | 10.49M | 10.49M | 5.22M | 7.26M | 2.5M | 11.69M | -575K | 37.17M | 8.11M | 7.55M | -4.14M | 7.99M | 13.44M | -14.37M |
Other Non-Cash Items | -1.44M | 25.12M | -8.31M | -10.14M | 88.93M | 2.25M | -15.16M | -6.9M | -8.18M | -8.39M | -4.77M | -5.16M | -3.15M | -969K | 219K | 2.58M | 3.57M | 6.1M | 4.69M | 5M | 2.35M | 2.06M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -19.11M | -15.41M | 22.64M | 10.91M | -16.51M | 54.85M | -24.35M | -40.36M | 10.49M | 210.49M | -203.97M | 52.56M | -79.08M | 36.91M | -31.62M | 37.19M | 8.19M | 6.1M | 18.49M | 9.3M | 13.44M | -14.37M |
Operating Cash Flow | -192.4M | -108.9M | -92.55M | -84.63M | -113.88M | -53.95M | -50.03M | -106.91M | -95.58M | 109.75M | -96.07M | -39.86M | -133.25M | 8.8M | -113.33M | -105.22M | -141.96M | -135.24M | -86.04M | -81.33M | 807M | -100.66M |
Capital Expenditures | -1.15M | -504K | -517K | -74K | -117K | -206K | -254K | -219K | -707K | -721K | -738K | -2.12M | -3.56M | -3.06M | -6.19M | -6.02M | -9.63M | -15.35M | -9.18M | -37.05M | -28.45M | -7.02M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -93.48M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -968.2M | -750.7M | -262.97M | -334.09M | -215.08M | -205.73M | -266.92M | -409.06M | -475.98M | -334.42M | -368.15M | -245.4M | -186.74M | -265.63M | -494.4M | -326.27M | -274M | -323.14M | -122.54M | -670.8M | -392.01M | -323.98M |
Sales Maturities Of Investments | 502.95M | 340.47M | 300.69M | 214.93M | 310.18M | 186.18M | 373M | 247.68M | 349.78M | 237.34M | 287.43M | 369.87M | 408.71M | 386.52M | 325.06M | 419.75M | 227.55M | 223.98M | 123.01M | 142.67M | 126.82M | 163.1M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | -25M | n/a | n/a | n/a | n/a | n/a | n/a | -1M | -1.5M | n/a | n/a | 93.48M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -466.4M | -410.74M | 37.2M | -119.23M | 69.98M | -19.76M | 105.83M | -161.6M | -126.91M | -97.8M | -81.45M | 121.35M | 216.92M | 117.83M | -175.53M | 87.46M | -56.07M | -114.52M | -8.72M | -565.18M | -293.64M | -167.9M |
Debt Repayment | 600M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.77M | 11.4M |
Common Stock Repurchased | -722K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -14.65M | n/a | n/a | 18.66M | n/a | 2.07M | 1.92M | 3.64M | 546K | 25.19M | n/a | n/a | n/a | n/a | n/a | 14.14M | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 599.09M | 591.91M | 116.41M | 296.77M | 2.26M | 10.59M | 16.88M | 9.64M | -466K | 305.93M | 38.94M | 1.56M | 16.77M | 5.4M | 2.48M | 15.11M | 10.35M | 10.65M | 6.3M | 10.21M | 8.44M | 225.99M |
Net Cash Flow | -59.74M | 68.52M | 61.06M | 92.88M | -41.57M | -63.07M | 72.59M | -258.8M | -222.95M | 317.88M | -138.29M | 82.97M | 100.39M | 132.52M | -282.27M | -2.74M | -187.74M | -239.13M | -88.52M | -635.1M | 521.81M | -42.57M |
Free Cash Flow | -193.55M | -109.4M | -93.07M | -84.71M | -114M | -54.15M | -50.29M | -107.13M | -96.29M | 109.03M | -96.81M | -41.97M | -136.8M | 5.74M | -119.52M | -111.24M | -151.59M | -150.59M | -95.22M | -118.38M | 778.55M | -107.69M |
Adj. Free Cash Flow | -227.19M | -109.4M | -111.15M | -101.31M | -131.6M | -74.37M | -72.23M | -128.68M | -119.96M | 89.63M | -115.23M | -61.94M | -158.57M | -15.14M | -142.32M | -135.78M | -176.44M | -176.33M | -120.99M | -144.58M | 750.22M | -129.78M |
Maintenance CapEx | -1.15M | -504K | -517K | n/a | n/a | n/a | -254K | n/a | -707K | -721K | n/a | -2.12M | n/a | n/a | -6.19M | -6.02M | -9.63M | -15.35M | -3.81M | -36.97M | n/a | -7M |
Growth CapEx | n/a | n/a | n/a | -74K | -117K | -206K | n/a | -219K | n/a | n/a | -738K | n/a | -3.56M | -3.06M | n/a | n/a | n/a | n/a | -5.38M | -77.66K | -28.45M | -19.31K |
Owner Earnings | -193.55M | -109.4M | -93.07M | -84.63M | -113.88M | -53.95M | -50.29M | -106.91M | -96.29M | 109.03M | -96.07M | -41.97M | -133.25M | 8.8M | -119.52M | -111.24M | -151.59M | -150.59M | -89.85M | -118.3M | 807M | -107.67M |
Add to Watchlist
Select watchlists to add or remove CRSP